Development and Validation of a Method for Quantification of Favipiravir as COVID-19 Management in Spiked Human Plasma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and Validation of a Method for Quantification of Favipiravir as COVID-19 Management in Spiked Human Plasma
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 13, Pages 3789
Publisher
MDPI AG
Online
2021-06-23
DOI
10.3390/molecules26133789
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence of human metabolites of omeprazole and its structure elucidation by using HPLC-MS
- (2021) Ramadan Al-Shdefat et al. JOURNAL OF MOLECULAR STRUCTURE
- A novel LC-MS/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma: Application to a bioequivalence study in Egyptian human volunteers
- (2021) Mosaad I. Morsy et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)
- (2020) Catrin Sohrabi et al. International Journal of Surgery
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19)
- (2020) Rui-fang Zhu et al. Journal of Translational Medicine
- The Rationale for Potential Pharmacotherapy of COVID-19
- (2020) Maha Saber-Ayad et al. Pharmaceuticals
- Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database
- (2020) Rimple Jeet Kaur et al. Infection and Drug Resistance
- Detection and quantification of Covid-19 antiviral drugs in biological fluids and tissues
- (2020) Maria A. Acquavia et al. TALANTA
- HPLC-UV method for quantification of favipiravir in pharmaceutical formulations
- (2020) İbrahim Bulduk ACTA CHROMATOGRAPHICA
- Laboratory findings, compassionate use of favipiravir, and outcome in patients with Ebola virus disease, Guinea, 2015 — a retrospective observational study
- (2019) Romy Kerber et al. JOURNAL OF INFECTIOUS DISEASES
- Quality Assessment of Medicinal Product and Dietary Supplements Containing Vitex agnus-castus by HPLC Fingerprint and Quantitative Analyses
- (2019) Mami Sogame et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Crucial importance of evaluating internal standards (IS) response and troubleshooting in effective LCMS method development, validation and sample analysis
- (2019) Seongeun Julia Cho et al. Bioanalysis
- Using HPLC to analyze (S)-oxiracetam and four related substances in the bulk drug of (S)-oxiracetam
- (2019) Chao Wang et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted
- (2017) Thi Huyen Tram Nguyen et al. PLoS Neglected Tropical Diseases
- Favipiravir (T-705), a novel viral RNA polymerase inhibitor
- (2013) Yousuke Furuta et al. ANTIVIRAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started